Breaking News Bar

Business News and Information

An early pioneer in gene-based drugs, Idera finds sudden success in cancer

Last year, Idera Pharmaceuticals shifted focus from autoimmune diseases to cancer, and saw a sudden stock spike after a promising early-stage trial...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear